Related Experiment Video

Updated: Jul 29, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.3K

Protein Phosphatase 2A: Role in T Cells and Diseases

Suyasha Roy1,2, Lalit Batra3

  • 1Immuno-Biology Laboratory, Translational Health Science and Technology Institute, Faridabad, India.

Journal of Immunology Research
|May 26, 2023
PubMed

Insights

Protein phosphatase 2A (PP2A) regulates T cell differentiation and immune responses. Its dysregulation is implicated in autoimmune diseases like lupus and multiple sclerosis, highlighting its therapeutic potential.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Protein phosphatase 2A (PP2A) is a crucial serine-threonine phosphatase regulating cell proliferation and signal transduction.
  • PP2A activity is essential for physiological functions, and its impairment severely affects cellular processes.
  • PP2A plays a vital role in T cell activation, differentiation, and function.

Purpose of the Study:

  • To review the structure and diverse functions of PP2A in T cell differentiation.
  • To explore the role of PP2A in various immune-related diseases.
  • To discuss the therapeutic applications of PP2A-mediated immunotherapy.

Main Methods:

  • Literature review focusing on PP2A's role in T cell subsets (Th1, Th2, Th17, Tregs, Th9).
  • Analysis of PP2A's involvement in the pathogenesis of systemic lupus erythematosus (SLE) and experimental autoimmune encephalomyelitis (EAE).
  • Examination of clinical applications of PP2A modulation for diseases like multiple sclerosis (MS).

Main Results:

  • PP2A differentially regulates T helper cell differentiation, suppressing Th1 and promoting Th2 and Th9 cells.
  • PP2A fosters Th17 differentiation, contributing to SLE pathogenesis.
  • PP2A is critical for Treg development and function; its genetic deletion impairs immunosuppression via mTORC1 signaling.
  • PP2A activation reduces neuroinflammation in EAE models.

Conclusions:

  • PP2A is a key regulator of T cell differentiation and immune homeostasis.
  • Dysregulation of PP2A is linked to autoimmune diseases and neuroinflammation.
  • Targeting PP2A offers a promising therapeutic strategy for various immune-mediated conditions.

More Related Videos

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

426
Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays09:36

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

6.8K

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K